Latest News & Features
Big Pharma
The EU General Court has backed the European Commission’s decision to fine pharma company Lundbeck and a number of generic producers. 12 September 2016
Americas
The US Court of Appeals for the Federal Circuit affirmed a ruling from a district court yesterday in a case between UCB and Yeda Research and Development, finding that UCB did not infringe the patent in dispute. 9 September 2016
Americas
The US Federal Trade Commission announced yesterday that it has approved a final order in Mylan’s $7.2 billion acquisition of Meda, a Swedish drug maker, deciding that the activity would be anticompetitive. 9 September 2016
Americas
Aralez Pharmaceuticals has acquired the US and Canadian rights to Zontivity in an agreement with Merck. 8 September 2016
Asia
Japan’s government officials have warned the UK that the Asian country may reconsider its research and development activities in the UK following Brexit. 8 September 2016
Americas
The US District Court for the Southern District of Florida ruled yesterday that Apotex did not infringe Amgen patents centring on its biologic drug Neulasta. 7 September 2016
Americas
Eli Lilly has filed a complaint against Aurobindo Pharma for allegedly infringing a patent covering the drug Cialis. 7 September 2016
Asia-Pacific
More than 2,000 medicine brands treating common conditions will drop in price for millions of Australians from October 1, according to the Australian government’s Department of Health. 6 September 2016
Big Pharma
Pharmaceutical company Alvogen has launched the first generic version of Copaxone in Europe under the name Remurel. 6 September 2016
Big Pharma
The Francis Crick Institute, Europe’s biggest biomedical research institute, has opened in London. 5 September 2016